Cargando…

Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists

Takeda G-protein-coupled receptor 5 (TGR5) is emerging as an important and promising target for the development of anti-diabetic drugs. To understand the structural characteristics of TGR5 agonists, the common feature pharmacophore models were generated and molecular docking was performed. The ligan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shizhen, Li, Xinping, Peng, Wenjing, Wang, Le, Ye, Wenling, Zhao, Yang, Yin, Wenbo, Chen, Wei-Dong, Li, Weiguo, Wang, Yan-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695346/ https://www.ncbi.nlm.nih.gov/pubmed/35423434 http://dx.doi.org/10.1039/d0ra10168k

Ejemplares similares

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Design, synthesis and evaluation of 3-phenoxypyrazine-2-carboxamide derivatives as potent TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2022)

Pharmacophore‐guided Virtual Screening to Identify New β(3)‐adrenergic Receptor Agonists
por: Ujiantari, Navista Sri Octa, et al.
Publicado: (2022)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
por: Li, Na, et al.
Publicado: (2022)

Pharmacophore-Aided Virtual Screening and Molecular Dynamics Simulation Identifies TrkB Agonists for Treatment of CDKL5-Deficiency Disorders
por: Ademuwagun, Ibitayo Abigail, et al.
Publicado: (2023)

Discovery of New Liver X Receptor Agonists by Pharmacophore Modeling and Shape-Based Virtual Screening
por: Temml, Veronika, et al.
Publicado: (2014)

Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores
por: Lagarde, Nathalie, et al.
Publicado: (2016)

Novel scaffolds for modulation of TRPV1 identified with pharmacophore modeling and virtual screening
por: Goldmann, Daria, et al.
Publicado: (2015)

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
por: Guzelj, Samo, et al.
Publicado: (2022)

Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening
por: Chen, Lei, et al.
Publicado: (2014)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Pharmacophore and Virtual Screening of JAK3 inhibitors
por: Rajeswari, Murugesan, et al.
Publicado: (2014)

Drug Design by Pharmacophore and Virtual Screening Approach
por: Giordano, Deborah, et al.
Publicado: (2022)

TGR5, Not Only a Metabolic Regulator
por: Guo, Cong, et al.
Publicado: (2016)

TGR5 agonists induce peripheral and central hypersensitivity to bladder distension
por: Caldwell, Ashlee, et al.
Publicado: (2022)

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
por: Gaurav, Anand, et al.
Publicado: (2017)

A Selective Pharmacophore Model for β(2)-Adrenoceptor Agonists
por: Xing, Rui-Juan, et al.
Publicado: (2009)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Combining docking with pharmacophore filtering for improved virtual screening
por: Peach, Megan L, et al.
Publicado: (2009)

Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
por: Madzhidov, Timur I., et al.
Publicado: (2020)

Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists
por: Gianella-Borradori, Matteo, et al.
Publicado: (2015)

Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors
por: Vuorinen, Anna, et al.
Publicado: (2014)

Identification of Novel HIV 1- Protease Inhibitors: Application of Ligand and Structure Based Pharmacophore Mapping and Virtual Screening
por: Yadav, Divya, et al.
Publicado: (2012)

Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening
por: Halim, Sobia A., et al.
Publicado: (2017)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
por: Kutlushina, Alina, et al.
Publicado: (2018)

Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
por: Lo, Shih-Hsiang, et al.
Publicado: (2016)

Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
por: Miyata, Sachiho, et al.
Publicado: (2021)

Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies
por: Ghorayshian, Atefeh, et al.
Publicado: (2023)

Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles
por: Lans, Isaias, et al.
Publicado: (2020)

Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies
por: Mathpal, Deepti, et al.
Publicado: (2021)

Ligand-based pharmacophore modeling and QSAR approach to identify potential dengue protease inhibitors
por: Poola, Anushka A., et al.
Publicado: (2023)

Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects
por: Chaudhari, Snehal N., et al.
Publicado: (2020)

In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
por: Sahayarayan, Jesudass Joseph, et al.
Publicado: (2021)

Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1
por: Molla, Mohammad Habibur Rahman, et al.
Publicado: (2023)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma
por: Opo, F A Dain Md, et al.
Publicado: (2022)

The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
por: Huang, Ting-Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfugiontft99s3f08glgnb3gkn